Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bithionol (Actamer), formerly marketed as an active ingredient in various topical drug products, was shown to be a potent photosensitizer with the potential to cause serious skin disorders. Approvals of the NDA's for bithionol drug products were withdrawn on October 24, 1967.
説明 | Bithionol (Actamer), formerly marketed as an active ingredient in various topical drug products, was shown to be a potent photosensitizer with the potential to cause serious skin disorders. Approvals of the NDA's for bithionol drug products were withdrawn on October 24, 1967. |
ターゲット&IC50 | sAC:4.0 μM |
細胞研究 | Ovarian cancer cell lines (5 × 103 cells/well) were plated into 96-well flat bottom plates (Corning, Inc., Corning, NY) and incubated for overnight. Cells were treated with different concentrations of BT ranging from 0.178 μM to 400 μM and further incubated for 48 hrs or 72 hrs. (Only for Reference) |
別名 | Actamer |
分子量 | 356.05 |
分子式 | C12H6Cl4O2S |
CAS No. | 97-18-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 66 mg/mL (185.4 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: 21 mg/mL (59 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bithionol 97-18-7 GPCR/G Protein Microbiology/Virology cAMP Parasite allosteric Actamer 4-4 cell Inhibitor adenylate cyclase Infection cestode inhibit Bacterial inhibitor